Total syntheses of (+)- and (-)-cacospongionolide B: New insight into structural requirements for phospholipase A2 inhibition

Journal of the American Chemical Society

Volumn 124, Issue 39, 2002, Pages 11584-11585

  Cheung, Atwood K ^a   Snapper, Marc L ^a  

^a BOSTON COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CACOSPONGIONOLIDE B; PHOSPHOLIPASE A2 INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; SPONGE (PORIFERA); STRUCTURE ACTIVITY RELATION;

4-BUTYROLACTONE; ENZYME INHIBITORS; PHOSPHOLIPASES A; PYRANS; STEREOISOMERISM;

EID: 0037009967     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja026899x     Document Type: Article

References (27)

1. (a) De Rosa, S.; Crispino, A.; De Giulio, A.; lodice, C. J. Nat. Prod. 1995, 58, 1776-1780.
2. (b) Soriente, A.; Crispino, A.; De Rosa, M.; De Rosa, S.; Scettri, A.; Scognamiglio, G.; Villano, R.; Sodano, G. Eur. J. Org. Chem. 2000, 947-955.
3. Garcia Pastor, P.; De Rosa, S.; De Giulio. A.; Payá, M.; Alcarza, M. J. Brit. J. Pharm. 1999, 126, 301-311.
4. Heller, A.; Koch, T.; Schmeck, J.; van Ackern, K. Drugs 1998, 55, 487-496.
5. De Silva, E. D.; Scheuer. P. J. Tetrahedron Lett. 1980, 21, 1611-1614.
6. (a) Potts, B. C. M.; Faulkner, D. J. J. Nat. Prod. 1992, 55, 1701-1717.
7. (b) Potts, B. C. M.; Faulkner, D. J.; De Carvalho, M. S.; Jacobs, R. S. J. Am. Chem. Soc. 1992, 114, 5093-5100.
8. (a) De Rosa, M.; Solladiê-Cavallo, A.; Scettri, A Tetrahedron Lett. 2000. 41, 1593-1596.
9. (b) De Rosa, M.; Soriente, A.; Sodano, G.; Scettri, A. Tetrahedron 2000, 56, 2095-2102.
10. (c) De Rosa, M.; Dell'Aglio, R.; Soriente, A.; Scettri, A Tetrahedron: Asymmetry 1999, 10, 3659-3662 and references therein.
11. Reported at the 223rd ACS National Meeting, Orlando, FL, April 7-11, 2002; American Chemical Society: Washington, DC, 2002; ORGN-434.
12. (a) Smith, A. B., III; Mewshaw, R. J. Org. Chem. 1984, 49, 3485-3489.
13. (b) Larsen, S. D.; Monti, S. A. J. Am. Chem. Soc. 1977, 99, 8015-8020.
14. Racherla, U. S.; Liao, Y.; Brown, H. C. J. Org. Chem. 1992, 57, 6614-6617.
15. Piscopio, A. D.; Minowa, N.; Chakraborty, T. K.; Koide, K.; Bertinato, P.; Nicolaou, K. C. J. Chem. Soc., Chem. Commun. 1993, 617-618.
16. Enone 9 was prepared in >99% ee after recrystallization using a D-phenylalanine-mediated enantioselective Robinson annulation, followed by protection of C-4 ketone. (a) Uma, R.; Swaminathan, S.; Rajagopalan, K. Tetrahedron Lett. 1984, 25, 5825-5828. (b) Hagiwara, H.; Uda, H. J. Org. Chem. 1988, 53, 2308-2311.
17. Enone 9 was prepared in >99% ee after recrystallization using a D-phenylalanine-mediated enantioselective Robinson annulation, followed by protection of C-4 ketone. (a) Uma, R.; Swaminathan, S.; Rajagopalan, K. Tetrahedron Lett. 1984, 25, 5825-5828. (b) Hagiwara, H.; Uda, H. J. Org. Chem. 1988, 53, 2308-2311.
18. (a) Stork, G.; Rosen, P.; Goldman, N.; Coombs, R. V.; Tsujji, J. J. Am. Chem. Soc. 1965, 87, 275-286.
19. (b) Stork, G.; Ganem, B. J. Am. Chem. Soc. 1973, 95, 6152-6153.
20. (c) Boeckman, R. K. J. Am. Chem. Soc. 1973, 95, 6867-6869.
21. 1H NMR (i.e., < 3%).
22. Scholl, M.; Ding, S.; Lee, C. W.; Grubbs, R. H. Org. Lett. 1999, 1, 953-956.
23. Harmon, R. E.; Gupta, S. K.; Brown, D. J. Chem. Rev. 1973, 73, 21-52.
24. Ohta, T.; Ikegami, H.; Miyake, T.; Takaya, H. J. Organomet. Chem. 1995, 502, 169-176.
25. Stereochemistry confirmed through single-crystal X-ray analysis
26. (a) Kernan, M. R.; Faulkner, D. J. J. Org. Chem. 1988, 53, 2773-2776.
27. (b) Demeke, D.; Forsyth, C. J. Org. Lett. 2000, 2, 3177-3179. Synthetic material was identical to samples provided by Dr. Salvatore De Rosa.